Trial Parameters
Condition Metastatic Cancer
Sponsor Indiana University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,600
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-01-26
Completion 2028-12
All Conditions
Interventions
Social Determinants of Health and toxicity questionnaires
Brief Summary
This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.
Eligibility Criteria
Inclusion Criteria: 1. Ability to provide written informed consent and HIPAA authorization 2. Patients must be ≥ 18 years old at the time of consent 3. Patients planning to undergo molecular testing as part of their routine cancer care Exclusion Criteria: N/A
Related Trials
NCT06533059
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
View Trial →
NCT07269080
STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Study
View Trial →
NCT05831579
Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy
View Trial →